1YK0 - JenaLib

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Title :   STRUCTURE OF NATRIURETIC PEPTIDE RECEPTOR-C COMPLEXED WITH ATRIAL NATRIURETIC PEPTIDE

Authors :   X. He, K. C. Garcia

Date :   16 Jan 05 (Deposition) - 18 Apr 06 (Release) - 13 Jul 11 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.40

Chains :   Asym. Unit : A,B,E  (2x)
Biol. Unit 1: A,B,E  (1x)

Keywords :   Hormone-Receptor Complex, Natriuretic Peptide Receptor, Allosteric Activation, Hormone-Growth Factor Receptor Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   X. L. He, A. Dukkipati, K. C. Garcia
Structural Determinants Of Natriuretic Peptide Receptor Specificity And Degeneracy.
J. Mol. Biol. V. 361 698 2006
PubMed-ID: 16870210 | Reference-DOI: 10.1016/J.JMB.2006.06.060

Molecule 1 - ATRIAL NATRIURETIC PEPTIDE CLEARANCE RECEPTOR
	Chains	:	A, B
	Engineered	:	YES
	Expression System	:	DROSOPHILA MELANOGASTER
	Expression System Common	:	FRUIT FLY
	Expression System Plasmid	:	PRMHA3
	Expression System Strain	:	S2
	Expression System Taxid	:	7227
	Expression System Vector Type	:	PLASMID
	Gene	:	NPR3, ANPRC
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	ANP-C, ANPRC, NPR-C, ATRIAL NATRIURETIC PEPTIDE C-TYPE RECEPTOR

Molecule 2 - ATRIAL NATRIURETIC FACTOR
	Chains	:	E
	Engineered	:	YES
	Other Details	:	THIS SEQUENCE OCCURS NATURALLY IN HUMANS.
	Synthetic	:	YES

		1	2	3
Asymmetric Unit (2x)	:	A	B	E
Biological Unit 1 (1x)	:	A	B	E

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (2, 7)

No.	Name	Count	Type	Full Name
1	CL	2	Ligand/Ion	CHLORIDE ION
2	NAG	5	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE

Biological Unit 1 (1, 5)

No.	Name	Count	Type	Full Name
1	CL	-1	Ligand/Ion	CHLORIDE ION
2	NAG	5	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE

Asymmetric Unit (7, 7)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	LEU A:21 , ASN A:248 , GLU A:306	BINDING SITE FOR RESIDUE NAG A 511
2	AC2	SOFTWARE	ASN A:349 , ALA A:363	BINDING SITE FOR RESIDUE NAG A 512
3	AC3	SOFTWARE	SER B:19 , LEU B:21 , ASN B:248 , SER B:251 , GLU B:306 , NAG B:437	BINDING SITE FOR RESIDUE NAG B 436
4	AC4	SOFTWARE	ASP B:220 , NAG B:436	BINDING SITE FOR RESIDUE NAG B 437
5	AC5	SOFTWARE	ASN B:349	BINDING SITE FOR RESIDUE NAG B 511
6	AC6	SOFTWARE	PRO A:15 , SER A:61 , PRO A:89 , VAL A:90 , CYS A:91	BINDING SITE FOR RESIDUE CL A 513
7	AC7	SOFTWARE	SER B:61 , PRO B:89 , VAL B:90 , CYS B:91	BINDING SITE FOR RESIDUE CL B 512

Asymmetric Unit

No.	Residues
1	A:63	-	A:91
2	A:168	-	A:216
3	B:63	-	B:91
4	B:168	-	B:216
5	E:7	-	E:23

Asymmetric Unit

No.	Model	Residues
1	1, 2	Gly A:88	-	Pro A:89
2	1, 2	Gly B:88	-	Pro B:89

(no "SAP(SNP)/Variant" information available for 1YK0)

Asymmetric Unit (2, 3)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	NATRIURETIC_PEPTIDE	PS00263	Natriuretic peptides signature.	ANF_HUMAN	130-146	1	E:7-23
2	ANF_RECEPTORS	PS00458	Natriuretic peptides receptors signature.	ANPRC_HUMAN	133-150	2	A:88-105 B:88-105

Biological Unit 1 (2, 3)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	NATRIURETIC_PEPTIDE	PS00263	Natriuretic peptides signature.	ANF_HUMAN	130-146	1	E:7-23
2	ANF_RECEPTORS	PS00458	Natriuretic peptides receptors signature.	ANPRC_HUMAN	133-150	2	A:88-105 B:88-105

Asymmetric Unit (6, 12)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.3a	ENST00000265074	3a	ENSE00001917259	chr5:32711540-32712651	1112	ANPRC_HUMAN	1-257	257	2	A:2-212 (gaps) B:2-212 (gaps)	211 211
1.5	ENST00000265074	5	ENSE00000735248	chr5:32724804-32724926	123	ANPRC_HUMAN	257-298	42	2	A:212-253 B:212-253	42 42
1.6	ENST00000265074	6	ENSE00000971354	chr5:32738970-32739136	167	ANPRC_HUMAN	298-353	56	2	A:253-308 B:253-308	56 56
1.7	ENST00000265074	7	ENSE00002059415	chr5:32774814-32774949	136	ANPRC_HUMAN	354-399	46	2	A:309-354 B:309-354	46 46
1.8	ENST00000265074	8	ENSE00001082097	chr5:32780828-32780922	95	ANPRC_HUMAN	399-430	32	2	A:354-385 B:354-385	32 32
1.9a	ENST00000265074	9a	ENSE00002167695	chr5:32782999-32783134	136	ANPRC_HUMAN	431-476	46	2	A:386-401 B:386-401	16 16
1.10a	ENST00000265074	10a	ENSE00001164694	chr5:32784902-32784989	88	ANPRC_HUMAN	476-505	30	0	-	-
1.11d	ENST00000265074	11d	ENSE00001938989	chr5:32786340-32787256	917	ANPRC_HUMAN	505-541	37	0	-	-

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:394
 aligned with ANPRC_HUMAN | P17342 from UniProtKB/Swiss-Prot  Length:541

    Alignment length:400
                                    56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446
          ANPRC_HUMAN    47 ALPPQKIEVLVLLPQDDSYLFSLTRVRPAIEYALRSVEGNGTGRRLLPPGTRFQVAYEDSDCGNRALFSLVDRVAAARGAKPDLILGPVCEYAAAPVARLASHWDLPMLSAGALAAGFQHKDSEYSHLTRVAPAYAKMGEMMLALFRHHHWSRAALVYSDDKLERNCYFTLEGVHEVFQEEGLHTSIYSFDETKDLDLEDIVRNIQASERVVIMCASSDTIRSIMLVAHRHGMTSGDYAFFNIELFNSSSYGDGSWKRGDKHDFEAKQAYSSLQTVTLLRTVKPEFEKFSMEVKSSVEKQGLNMEDYVNMFVEGFHDAILLYVLALHEVLRAGYSKKDGGKIIQQTWNRTFEGIAGQVSIDANGDRYGDFSVIAMTDVEAGTQEVIGDYFGKEGRFEMRP 446
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains 1yk0A01 A:2-134,A:284-368  [code=3.40.5      0.2300, no name defined]                                                                1yk0A02 A:135-281,A:369-400  [code=3.40.50.2300, no name defined]                                                                                  --1yk0A01 A:2-134,A:284-368  [code=3.40.50.2300, no name defined]                      1yk0A02 A:135-281,A:369-400     - CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....eeeeeeee........hhhhhhhhhhhhhhhhh.------......eeeeeeee....hhhhhhhhhhhhhh......eee...hhhhhhhhhhhhhhh...eee....hhhhhh.......eee...hhhhhhhhhhhhhhhhh..eeeeeee.....hhhhhhhhhhhhhhhhhh.eeeeeee......hhhhhhhhhhhh..eeeee.hhhhhhhhhhhhhh........eeeee..................hhhhhhhhh..eeeeee....hhhhhhhhhhhhhhhhh.........hhhhhhhhhhhhhhhhhhhhhhh......hhhhhhhhhh.eeee....eeee........eeeeeeeee....eeeeeeeee....eeee.. Sec.struct. author
                 SAPs(SNPs) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (2) --------------------------------------------------------------------------------------ANF_RECEPTORS     -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.3a  PDB: A:2-212 (gaps) UniProt: 1-257 [INCOMPLETE]                                                                                                                                                         ----------------------------------------Exon 1.6  PDB: A:253-308 UniProt: 298-353               Exon 1.7  PDB: A:309-354 UniProt: 354-399     -------------------------------Exon 1.9a        Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.5  PDB: A:212-253 UniProt: 257-298 ----------------------------------------------------------------------------------------------------Exon 1.8  PDB: A:354-385        ---------------- Transcript 1 (2)
                 1yk0 A   2 ALPPQKIEVLVLLPQDDSYLFSLTRVRPAIEYALRSVEG------LLPPGTRFQVAYEDSDCGNRALFSLVDRVAAARGAKPDLILGPVCEYAAAPVARLASHWDLPMLSAGALAAGFQHKDSEYSHLTRVAPAYAKMGEMMLALFRHHHWSRAALVYSDDKLERNCYFTLEGVHEVFQEEGLHTSIYSFDETKDLDLEDIVRNIQASERVVIMCASSDTIRSIMLVAHRHGMTSGDYAFFNIELFNSSSYGDGSWKRGDKHDFEAKQAYSSLQTVTLLRTVKPEFEKFSMEVKSSVEKQGLNMEDYVNMFVEGFHDAILLYVLALHEVLRAGYSKKDGGKIIQQTWNRTFEGIAGQVSIDANGDRYGDFSVIAMTDVEAGTQEVIGDYFGKEGRFEMRP 401
                                    11        21        31        |-     |  51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401
                                                                 40     47

Chain B from PDB  Type:PROTEIN  Length:394
 aligned with ANPRC_HUMAN | P17342 from UniProtKB/Swiss-Prot  Length:541

    Alignment length:400
                                    56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446
          ANPRC_HUMAN    47 ALPPQKIEVLVLLPQDDSYLFSLTRVRPAIEYALRSVEGNGTGRRLLPPGTRFQVAYEDSDCGNRALFSLVDRVAAARGAKPDLILGPVCEYAAAPVARLASHWDLPMLSAGALAAGFQHKDSEYSHLTRVAPAYAKMGEMMLALFRHHHWSRAALVYSDDKLERNCYFTLEGVHEVFQEEGLHTSIYSFDETKDLDLEDIVRNIQASERVVIMCASSDTIRSIMLVAHRHGMTSGDYAFFNIELFNSSSYGDGSWKRGDKHDFEAKQAYSSLQTVTLLRTVKPEFEKFSMEVKSSVEKQGLNMEDYVNMFVEGFHDAILLYVLALHEVLRAGYSKKDGGKIIQQTWNRTFEGIAGQVSIDANGDRYGDFSVIAMTDVEAGTQEVIGDYFGKEGRFEMRP 446
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains 1yk0B01 B:2-134,B:284-368  [code=3.40.5      0.2300, no name defined]                                                                1yk0B02 B:135-281,B:369-400  [code=3.40.50.2300, no name defined]                                                                                  --1yk0B01 B:2-134,B:284-368  [code=3.40.50.2300, no name defined]                      1yk0B02 B:135-281,B:369-400     - CATH domains
           Pfam domains (1) ------------------------ANF_receptor-1y      k0B01 B:26-379                                                                                                                                                                                                                                                                                                                               ---------------------- Pfam domains (1)
           Pfam domains (2) ------------------------ANF_receptor-1y      k0B02 B:26-379                                                                                                                                                                                                                                                                                                                               ---------------------- Pfam domains (2)
         Sec.struct. author .....eeeeeeee........hhhhhhhhhhhhhhh...------......eeeeeeee....hhhhhhhhhhhhhh......eee...hhhhhhhhhhhhhhh...eee....hhhhhh.......eee...hhhhhhhhhhhhhhhhh..eeeeeee.....hhhhhhhhhhhhhhhhhh.eeeeeee......hhhhhhhhhh....eeeee.hhhhhhhhhhhhhhh.......eeeee..................hhhhhhhhh..eeeeee....hhhhhhhhhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhhhhhh.....hhhhhhhh...eeeee..eeeee........eeeeeeeee....eeeeeeeee....eeee.. Sec.struct. author
                 SAPs(SNPs) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (2) --------------------------------------------------------------------------------------ANF_RECEPTORS     -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.3a  PDB: B:2-212 (gaps) UniProt: 1-257 [INCOMPLETE]                                                                                                                                                         ----------------------------------------Exon 1.6  PDB: B:253-308 UniProt: 298-353               Exon 1.7  PDB: B:309-354 UniProt: 354-399     -------------------------------Exon 1.9a        Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.5  PDB: B:212-253 UniProt: 257-298 ----------------------------------------------------------------------------------------------------Exon 1.8  PDB: B:354-385        ---------------- Transcript 1 (2)
                 1yk0 B   2 ALPPQKIEVLVLLPQDDSYLFSLTRVRPAIEYALRSVEG------LLPPGTRFQVAYEDSDCGNRALFSLVDRVAAARGAKPDLILGPVCEYAAAPVARLASHWDLPMLSAGALAAGFQHKDSEYSHLTRVAPAYAKMGEMMLALFRHHHWSRAALVYSDDKLERNCYFTLEGVHEVFQEEGLHTSIYSFDETKDLDLEDIVRNIQASERVVIMCASSDTIRSIMLVAHRHGMTSGDYAFFNIELFNSSSYGDGSWKRGDKHDFEAKQAYSSLQTVTLLRTVKPEFEKFSMEVKSSVEKQGLNMEDYVNMFVEGFHDAILLYVLALHEVLRAGYSKKDGGKIIQQTWNRTFEGIAGQVSIDANGDRYGDFSVIAMTDVEAGTQEVIGDYFGKEGRFEMRP 401
                                    11        21        31        |-     |  51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401
                                                                 40     47

Chain E from PDB  Type:PROTEIN  Length:21
 aligned with ANF_HUMAN | P01160 from UniProtKB/Swiss-Prot  Length:153

    Alignment length:21
                                   138       148 
            ANF_HUMAN   129 SCFGGRMDRIGAQSGLGCNSF 149
               SCOP domains --------------------- SCOP domains
               CATH domains --------------------- CATH domains
               Pfam domains --------------------- Pfam domains
         Sec.struct. author ..................... Sec.struct. author
                 SAPs(SNPs) --------------------- SAPs(SNPs)
                    PROSITE -NATRIURETIC_PEPTI--- PROSITE
                 Transcript --------------------- Transcript
                 1yk0 E   6 SCFGGRMDRIGAQSGLGCNSF  26
                                    15        25

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

(no "SCOP Domain" information available for 1YK0)

Asymmetric Unit

Classes(

)

Architectures( (-)

)

Topologies( (-)

)

Homologous Superfamilies( (-)

)

Organisms( (-)

)

Class: Alpha Beta (26913)

Architecture: 3-Layer(aba) Sandwich (12045)

Topology: Rossmann fold (7312)

Homologous Superfamily: [code=3.40.50.2300, no name defined] (308)

Human (Homo sapiens) (5)

1a	1yk0A02	A:135-281,A:369-400
1b	1yk0A01	A:2-134,A:284-368
1c	1yk0B01	B:2-134,B:284-368
1d	1yk0B02	B:135-281,B:369-400

Asymmetric Unit

Clans(

)

Families(

)

Organisms( (-)

)

Clan: Periplas_BP (97)

Family: ANF_receptor (21)

Homo sapiens (Human) (7)

1a	ANF_receptor-1yk0B01	B:26-379
1b	ANF_receptor-1yk0B02	B:26-379

Asymmetric Unit(hide GO term definitions)

Chain A,B (ANPRC_HUMAN | P17342)

molecular function
	GO:0008528	G-protein coupled peptide receptor activity	Combining with a peptide and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
	GO:0004016	adenylate cyclase activity	Catalysis of the reaction: ATP = 3',5'-cyclic AMP + diphosphate.
	GO:0042562	hormone binding	Interacting selectively and non-covalently with any hormone, naturally occurring substances secreted by specialized cells that affect the metabolism or behavior of other cells possessing functional receptors for the hormone.
	GO:0016941	natriuretic peptide receptor activity	Combining with a natriuretic peptide and transmitting the signal to initiate a change in cell activity.
	GO:0017046	peptide hormone binding	Interacting selectively and non-covalently with any peptide with hormonal activity in animals.
	GO:0042803	protein homodimerization activity	Interacting selectively and non-covalently with an identical protein to form a homodimer.
biological process
	GO:0007189	adenylate cyclase-activating G-protein coupled receptor signaling pathway	The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds through activation of adenylyl cyclase activity and a subsequent increase in the concentration of cyclic AMP (cAMP).
	GO:0007193	adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway	The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds through inhibition of adenylyl cyclase activity and a subsequent decrease in the concentration of cyclic AMP (cAMP).
	GO:0006171	cAMP biosynthetic process	The chemical reactions and pathways resulting in the formation of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
	GO:0019933	cAMP-mediated signaling	Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell.
	GO:0009190	cyclic nucleotide biosynthetic process	The chemical reactions and pathways resulting in the formation of a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue.
	GO:0048662	negative regulation of smooth muscle cell proliferation	Any process that stops, prevents or reduces the rate or extent of smooth muscle cell proliferation.
	GO:0002158	osteoclast proliferation	The multiplication or reproduction of osteoclasts, resulting in the expansion of an osteoclast cell population. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue, which typically differentiates from monocytes.
	GO:0030157	pancreatic juice secretion	The regulated release of pancreatic juice by the exocrine pancreas into the upper part of the intestine. Pancreatic juice is slightly alkaline and contains numerous enzymes and inactive enzyme precursors including alpha-amylase, chymotrypsinogen, lipase, procarboxypeptidase, proelastase, prophospholipase A2, ribonuclease, and trypsinogen. Its high concentration of bicarbonate ions helps to neutralize the acid from the stomach.
	GO:0048015	phosphatidylinositol-mediated signaling	A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
	GO:0007200	phospholipase C-activating G-protein coupled receptor signaling pathway	The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent increase in the concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG).
	GO:0051000	positive regulation of nitric-oxide synthase activity	Any process that activates or increases the activity of the enzyme nitric-oxide synthase.
	GO:0035810	positive regulation of urine volume	Any process that increases the amount of urine excreted from the body over a unit of time.
	GO:0008217	regulation of blood pressure	Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
	GO:0033688	regulation of osteoblast proliferation	Any process that modulates the frequency, rate or extent of osteoblast proliferation.
	GO:0001501	skeletal system development	The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
cellular component
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005887	integral component of plasma membrane	The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005622	intracellular	The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Chain E (ANF_HUMAN | P01160)

molecular function
	GO:0005179	hormone activity	The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
	GO:0005184	neuropeptide hormone activity	The action characteristic of a neuropeptide hormone, any peptide hormone that acts in the central nervous system. A neuropeptide is any of several types of molecules found in brain tissue, composed of short chains of amino acids; they include endorphins, enkephalins, vasopressin, and others. They are often localized in axon terminals at synapses and are classified as putative neurotransmitters, although some are also hormones.
	GO:0071855	neuropeptide receptor binding	Interacting selectively and non-covalently with a neuropeptide receptor.
	GO:0051428	peptide hormone receptor binding	Interacting selectively and non-covalently with a receptor for peptide hormones.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0005102	receptor binding	Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
biological process
	GO:0006182	cGMP biosynthetic process	The chemical reactions and pathways resulting in the formation of cyclic GMP, guanosine 3',5'-phosphate.
	GO:0014898	cardiac muscle hypertrophy in response to stress	The physiological enlargement or overgrowth of all or part of the heart muscle due to an increase in size (not length) of individual cardiac muscle fibers, without cell division, as a result of a disturbance in organismal or cellular homeostasis.
	GO:0061049	cell growth involved in cardiac muscle cell development	The growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.
	GO:0044267	cellular protein metabolic process	The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
	GO:0071260	cellular response to mechanical stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
	GO:0007565	female pregnancy	The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
	GO:0030308	negative regulation of cell growth	Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
	GO:1903815	negative regulation of collecting lymphatic vessel constriction	Any process that stops, prevents or reduces the frequency, rate or extent of collecting lymphatic vessel constriction.
	GO:0003085	negative regulation of systemic arterial blood pressure	The process that reduces the force with which blood travels through the systemic arterial circulatory system.
	GO:0007218	neuropeptide signaling pathway	The series of molecular signals generated as a consequence of a peptide neurotransmitter binding to a cell surface receptor.
	GO:0060452	positive regulation of cardiac muscle contraction	Any process that increases the frequency, rate or extent of cardiac muscle contraction.
	GO:1902261	positive regulation of delayed rectifier potassium channel activity	Any process that activates or increases the frequency, rate or extent of delayed rectifier potassium channel activity.
	GO:0010460	positive regulation of heart rate	Any process that activates or increases the frequency or rate of heart contraction.
	GO:1903766	positive regulation of potassium ion export across plasma membrane	Any process that activates or increases the frequency, rate or extent of potassium ion export across plasma membrane.
	GO:0007168	receptor guanylyl cyclase signaling pathway	A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses guanylyl cyclase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
	GO:0060372	regulation of atrial cardiac muscle cell membrane repolarization	Any process that modulates the establishment or extent of a membrane potential in the polarizing direction towards the resting potential in an atrial cardiomyocyte.
	GO:0008217	regulation of blood pressure	Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
	GO:0050880	regulation of blood vessel size	Any process that modulates the size of blood vessels.
	GO:1902514	regulation of calcium ion transmembrane transport via high voltage-gated calcium channel	Any process that modulates the frequency, rate or extent of generation of calcium ion transmembrane transport via high voltage-gated calcium channel.
	GO:1903779	regulation of cardiac conduction	Any process that modulates the frequency, rate or extent of cardiac conduction.
	GO:1901841	regulation of high voltage-gated calcium channel activity	Any process that modulates the frequency, rate or extent of high voltage-gated calcium channel activity.
	GO:0001666	response to hypoxia	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
	GO:0032868	response to insulin	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
	GO:0035994	response to muscle stretch	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a myofibril being extended beyond its slack length.
	GO:0006367	transcription initiation from RNA polymerase II promoter	Any process involved in the assembly of the RNA polymerase II preinitiation complex (PIC) at an RNA polymerase II promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription.
cellular component
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0042629	mast cell granule	Coarse, bluish-black staining cytoplasmic granules, bounded by a plasma membrane and found in mast cells and basophils. Contents include histamine, heparin, chondroitin sulfates, chymase and tryptase.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0048471	perinuclear region of cytoplasm	Cytoplasm situated near, or occurring around, the nucleus.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		CL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Gly A:88 - Pro A:89	[ RasMol ]
		Gly B:88 - Pro B:89	[ RasMol ]

Biological Unit
	Complete Structure
		Biological Unit 1	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	1yk0
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	ANF_HUMAN \| P01160
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt
	ANPRC_HUMAN \| P17342
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	(no 'Enzyme Classificator' available)
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	(no 'MIM ID' available)
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	ANF_HUMAN \| P01160
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)
	ANPRC_HUMAN \| P17342
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

UniProtKB/Swiss-Prot
	ANF_HUMAN \| P01160	:	1anp 3n57
	ANPRC_HUMAN \| P17342	:	1jdn 1jdp 1yk1

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (2, 7)

Sites (7, 7)

SS Bonds (5, 5)

Cis Peptide Bonds (2, 4)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (0, 0)

PROSITE Motifs (2, 3)

Exons (6, 12)

Sequences/Alignments

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (1, 4)

Pfam Domains (1, 2)

Gene Ontology (63, 64)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File